Expanding the clinical spectrum of biallelic ZNF335 variants

K Stouffs, A B Stergachis, T Vanderhasselt, A Dica, S Janssens, L Vandervore, A Gheldof, O Bodamer, K Keymolen, S Seneca, I Liebaers, D Jayaraman, H E Hill, J N Partlow, C A Walsh, A C Jansen

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

ZNF335 plays an essential role in neurogenesis and biallelic variants in ZNF335 have been identified as the cause of severe primary autosomal recessive microcephaly in two unrelated families. We describe herein two additional affected individuals with biallelic ZNF335 variants, one individual with a homozygous c.1399T>C, p.(Cys467Arg) variant, and a second individual with compound heterozygous c.2171_2173delTCT, p.(Phe724del) and c.3998A>G, p.(Glu1333Gly) variants in ZNF335; with the latter variant predicted to affect splicing. Whereas the first case presented with early death and a severe phenotype characterized by anterior agyria with prominent extra-axial spaces, absent basal ganglia, and hypoplasia of the brainstem and cerebellum, the second case had a milder clinical presentation with hypomyelination and otherwise preserved brain structures on MRI. Our findings expand the clinical spectrum of ZNF335 associated microcephaly.

Original languageEnglish
Pages (from-to)246-251
Number of pages6
JournalClinical Genetics
Volume94
Issue number2
Early online date13 Apr 2018
DOIs
Publication statusPublished - Aug 2018

Bibliographical note

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Keywords

  • basal ganglia
  • microcephaly
  • neurodegeneration
  • neurogenesis
  • ZNF335

Fingerprint

Dive into the research topics of 'Expanding the clinical spectrum of biallelic ZNF335 variants'. Together they form a unique fingerprint.

Cite this